Soleus Capital Management’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10M	Hold	3,803,942	–	–	0.41%	49
2025 Q4	$7.27M	Sell	3,803,942 -3,250,000	-46%	-$7.7M	0.27%	58
2025 Q3	$15.7M	Buy	7,053,942 +75,000	+1%	+$180K	0.79%	33
2025 Q2	$9.98M	Hold	6,978,942	–	–	0.66%	39
2025 Q1	$11.2M	Hold	6,978,942	–	–	0.8%	33
2024 Q4	$25.1M	Buy	6,978,942 +374,946	+6%	+$1.86M	1.58%	20
2024 Q3	$37.6M	Buy	6,603,996 +2,552,000	+63%	+$15.4M	2.91%	8
2024 Q2	$18.7M	Buy	4,051,996 +1,593,000	+65%	+$9.5M	1.65%	21
2024 Q1	$20.1M	Buy	2,458,996 +623,000	+34%	+$4.83M	1.49%	18
2023 Q4	$10.4M	Sell	1,835,996 -856,024	-32%	-$1.95M	1.15%	28
2023 Q3	$5.01M	Hold	2,692,020	–	–	0.46%	56
2023 Q2	$7.4M	Buy	2,692,020 +305,000	+13%	+$980K	0.82%	37
2023 Q1	$7.5M	Sell	2,387,020 -53,823	-2%	-$317K	0.78%	38
2022 Q4	$14.4M	Buy	2,440,843 +999,330	+69%	+$8.29M	2.07%	15
2022 Q3	$12.6M	Buy	1,441,513 +1,158,873	+410%	+$12M	1.72%	18
2022 Q2	$2.13M	Buy	282,640 +115,904	+70%	+$1.02M	0.33%	58
2022 Q1	$4.04M	Sell	166,736 -394,386	-70%	-$9.58M	0.52%	43
2021 Q4	$18.1M	Sell	561,122 -189,511	-25%	-$7.49M	1.81%	21
2021 Q3	$33.5M	Sell	750,633 -120,125	-14%	-$5.14M	5.23%	2
2021 Q2	$32.9M	Buy	870,758 +406,690	+88%	+$14.6M	5.07%	3
2021 Q1	$17.2M	Buy	464,068 +195,520	+73%	+$7.78M	3.09%	6
2020 Q4	$8.9M	Buy	+268,548	New	+$7.79M	1.17%	8